103 related articles for article (PubMed ID: 6122613)
1. The use of drug-receptor affinity measures in the differentiation of receptors.
Tallarida RJ
Fed Proc; 1982 May; 41(7):2323-7. PubMed ID: 6122613
[TBL] [Abstract][Full Text] [Related]
2. Receptor theories and quantitative effect versus dose-concentration relationship.
Tallarida RJ
Drug Metab Rev; 1984; 15(1-2):345-63. PubMed ID: 6745084
[TBL] [Abstract][Full Text] [Related]
3. The affinity of morphine for its pharmacologic receptor in vivo.
Tallarida RJ; Cowan A
J Pharmacol Exp Ther; 1982 Jul; 222(1):198-201. PubMed ID: 6283067
[TBL] [Abstract][Full Text] [Related]
4. Naloxazone treatment in the guinea pig ileum in vitro reveals second functional opioid receptor site.
James MK; Leighton HJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):138-44. PubMed ID: 3027301
[TBL] [Abstract][Full Text] [Related]
5. Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
Shannon HE; Cone EJ; Gorodetzky CW
J Pharmacol Exp Ther; 1984 Jun; 229(3):768-74. PubMed ID: 6547177
[TBL] [Abstract][Full Text] [Related]
6. Measuring naloxone antagonism of discriminative opioid stimulus.
Krimmer EC; Barry H
Fed Proc; 1982 May; 41(7):2319-22. PubMed ID: 7042395
[TBL] [Abstract][Full Text] [Related]
7. In vivo apparent pA2 analysis for naltrexone antagonism of discriminative stimulus and analgesic effects of opiate agonists in rats.
Walker EA; Makhay MM; House JD; Young AM
J Pharmacol Exp Ther; 1994 Nov; 271(2):959-68. PubMed ID: 7965818
[TBL] [Abstract][Full Text] [Related]
8. The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine.
Tallarida RJ; Harakal C; Maslow J; Geller EB; Adler MW
J Pharmacol Exp Ther; 1978 Jul; 206(1):38-45. PubMed ID: 660555
[TBL] [Abstract][Full Text] [Related]
9. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
10. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
11. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
Schmauss C; Yaksh TL
J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
[TBL] [Abstract][Full Text] [Related]
12. The Schild regression in the process of receptor classification.
Kenakin TP
Can J Physiol Pharmacol; 1982 Mar; 60(3):249-65. PubMed ID: 7042056
[TBL] [Abstract][Full Text] [Related]
13. Compartmentation of receptors and guanine nucleotide-binding proteins in NG108-15 cells: lack of cross-talk in agonist binding among the alpha 2-adrenergic, muscarinic, and opiate receptors.
Graeser D; Neubig RR
Mol Pharmacol; 1993 Mar; 43(3):434-43. PubMed ID: 8095695
[TBL] [Abstract][Full Text] [Related]
14. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
Sterious SN; Walker EA
J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
[TBL] [Abstract][Full Text] [Related]
15. Potency, duration of action and pA2 in man of intravenous naloxone measured by reversal of morphine-depressed respiration.
Kaufman RD; Gabathuler ML; Bellville JW
J Pharmacol Exp Ther; 1981 Oct; 219(1):156-62. PubMed ID: 7288605
[TBL] [Abstract][Full Text] [Related]
16. Agonist and antagonist effects of mixed action opioids in the pigeon drug discrimination procedure: influence of training dose, intrinsic efficacy and interanimal differences.
Picker MJ; Yarbrough J; Hughes CE; Smith MA; Morgan D; Dykstra LA
J Pharmacol Exp Ther; 1993 Aug; 266(2):756-67. PubMed ID: 8394915
[TBL] [Abstract][Full Text] [Related]
17. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874.
Gulati A; Bhalla S; Matwyshyn G; Zhang Z; Andurkar SV
Pharmacology; 2009; 83(1):45-58. PubMed ID: 19052482
[TBL] [Abstract][Full Text] [Related]
18. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
19. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
Cheng HC
Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
[TBL] [Abstract][Full Text] [Related]
20. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
Minneman KP; Fox AW; Abel PW
Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]